ELVN episode 20260612_ELVN_DAY
Public episode JSON embedded as readable text for automated access.
{
"schema_version": "tryding-agent-episode.v1",
"episode_id": "20260612_ELVN_DAY",
"episode_url": "https://trydingday.com/data/agents/v1/episodes/20260612_ELVN_DAY.html",
"public_page_url": "https://trydingday.com/2026/06/12/winner-elvn-june-12-2026/",
"published_at": "2026-06-12T18:03:28.972506Z",
"updated_at": "2026-06-12T18:03:28.972506Z",
"lifecycle": {
"tracking_status": "closed",
"active_for_tracking": false,
"stage": "closed"
},
"instrument": {
"type": "equity",
"symbol": "ELVN",
"exchange": "",
"name": "Enliven Therapeutics, Inc."
},
"technical_reference": {
"status": "unavailable",
"reason": "not_recorded_in_published_episode"
},
"public_content": {
"date": "June 12, 2026",
"generated_at": "2026-06-12T18:03:28.972506Z",
"original_published_at": null,
"session_tag": "day",
"label": "Market coverage",
"try_label": "Research status not recorded",
"public_status": "Research status not recorded",
"why_today": "",
"entry_reasoning": "",
"reference_price": 46.85,
"scanner": {
"price": 46.85,
"reference": 46.85,
"score": 6,
"score_version": "legacy research",
"change": 16.08,
"volume": null,
"average_volume": null,
"volume_ratio": 3.72,
"rsi": 60.81,
"ema_trend": "39.25 > 39.3 > 39.22",
"position_52w": 96.29,
"atr_14": null,
"vwap": null,
"vwap_state": null,
"vwap_distance_pct": null,
"vwap_reading": null,
"range_position": null,
"gap_pct": null,
"relative_strength": null,
"volume_percentile": null,
"extension": null,
"atr_move_signal": null,
"sector_breadth": null,
"sentiment": "Bullish",
"sentiment_score": 0.899,
"earnings_warning": null,
"options_snapshot": null,
"extended_hours": null,
"coiled_spring": null,
"short_pct_float": null,
"days_to_cover": null,
"catalyst": "Enliven Therapeutics reports positive Phase 1 ENABLE data; 80 mg QD set for Phase 3",
"sector": "Healthcare",
"exchange": null,
"sec_signal": "INSIDER_SELL (S/M)"
},
"levels": {
"reference": 46.85,
"downside": null,
"upside_1": null,
"upside_2": null
},
"review": {
"score": 6,
"status": "Recorded Review",
"summary": "",
"views": [],
"conviction": null,
"context_roundtable": null,
"context_roundtable_sources": []
},
"updates": [],
"observed_outcomes": [
{
"label": "+1 sessions",
"status": "complete",
"return": -9.58,
"reference_text": "-9.58% from $46.85 base",
"price": 42.36,
"updated": "Jun 17, 2026 · 15:25 NYSE",
"mfe": 0.32,
"mae": -11.59
},
{
"label": "+5 sessions",
"status": "complete",
"return": -1.9,
"reference_text": "-1.90% from $46.85 base",
"price": 45.96,
"updated": "Jul 14, 2026 · 12:37 NYSE",
"mfe": 3.56,
"mae": -12.59
},
{
"label": "+10 sessions",
"status": "complete",
"return": 8.54,
"reference_text": "+8.54% from $46.85 base",
"price": 50.85,
"updated": "Jun 28, 2026 · 16:49 NYSE",
"mfe": 8.99,
"mae": -12.59
},
{
"label": "+15 sessions",
"status": "complete",
"return": 8.69,
"reference_text": "+8.69% from $46.85 base",
"price": 50.92,
"updated": "Jul 11, 2026 · 04:43 NYSE",
"mfe": 11.82,
"mae": -12.59
}
],
"candidate_comparison_history": [],
"candidates": [],
"news": [],
"transcript_url": null,
"initial_transcript_anchor": "",
"chart_url": null,
"secondary_chart_url": null,
"forecast_chart_url": null,
"methodology_url": "https://trydingday.com/methodology/",
"track_record_url": "https://trydingday.com/track-record/",
"market_timezone": null
}
}